Gad Berdugo

Gad Berdugo is a seasoned business executive with expertise in biotechnology, biopharmaceuticals, cancer immunotherapy, precision medicine, molecular diagnostics, and gene & cellular therapies. He has more than 25 years of experience in business and corporate development, strategy, operational and financial management. Gad has worked with renowned companies such as Abbott, Baxter, and Lazard, and several emerging biotech companies. He has a B.Sc. (Hons.) in Biotechnology from Imperial College London, an MBA in General Management and Finance from HEC School of Management, an M.Sc. in Biochemical Engineering from University College London, and an MBA exchange in Venture Management and Healthcare Economics from the Kellogg School of Management at Northwestern University. Gad has held several senior positions in various organizations such as Editas Medicine, EpiVax Oncology, IMMUNE Pharmaceuticals Inc., Tegris LLC, Explorium Capital LLC, Lazard, Baxter Healthcare, and Abbott. His specialties include business and corporate development, venture management, strategic partnerships, M&A, financing, Nasdaq listing, due diligence, valuation, leadership, and team building. Gad is also a former member of the board of directors at Genome Profiling LLC and a steering committee member at Mid Atlantic Bio Angels. Overall, he is a prominent figure in biotech, and his experience and expertise have profoundly impacted the industry.